Спадковий неполіпозний колоректальний рак (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Спадковий неполіпозний колоректальний рак" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

52nih.gov

4^th place

5^th place

36doi.org

2^nd place

4^th place

11worldcat.org

5^th place

9^th place

4archive.org

6^th place

2web.archive.org

1^st place

2harvard.edu

18^th place

74^th place

2medscape.com

719^th place

441^st place

1dynamed.com

low place

1rug.nl

2,779^th place

8,149^th place

1genetics.edu.au

low place

1elsevierhealth.com

low place

1ama-assn.org

3,257^th place

6,919^th place

1archivesofpathology.org

low place

1oxfordjournals.org

1,389^th place

583^rd place

1archive.today

14^th place

18^th place

1jco.org

low place

1lynch-syndrome-uk.org

low place

1bowelcanceruk.org.uk

low place

1cdc.gov

218^th place

225^th place

ama-assn.org

jama.ama-assn.org

Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D (April 2005). Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 293 (16): 1979—85. doi:10.1001/jama.293.16.1979. PMC 2933042. PMID 15855431. {{cite journal}}: Недійсний |displayauthors=6 (довідка)

archive.org

Hoffman, Barbara L. (2012). Chapter 33: Endometrial Cancer. Williams Gynecology (вид. 2nd). New York: McGraw-Hill Medical. ISBN 978-0071716727. {{cite book}}: Недійсний |deadurl=vanc (довідка)
Giardiello, Francis M.; Allen, John I.; Axilbund, Jennifer E.; Boland, C. Richard; Burke, Carol A.; Burt, Randall W.; Church, James M.; Dominitz, Jason A.; Johnson, David A. (August 2014). Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 147 (2): 502—526. doi:10.1053/j.gastro.2014.04.001. PMID 25043945.
Vasen HF, Watson P, Mecklin JP, Lynch HT (June 1999). New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 116 (6): 1453—6. doi:10.1016/S0016-5085(99)70510-X. PMID 10348829.
Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, du Sart D, Tucker K, Kirk J (January 2001). Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. American Journal of Human Genetics. 68 (1): 118—127. doi:10.1086/316942. PMC 1234904. PMID 11112663. {{cite journal}}: Недійсний |displayauthors=6 (довідка)

archive.today

Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, Cranston T, Izatt L, Sasieni P, Hodgson SV, Thomas HJ, Tomlinson IP (December 2004). Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. Journal of Clinical Oncology. 22 (24): 4934—43. doi:10.1200/JCO.2004.11.084. PMID 15611508. Архів оригіналу за 15 квітня 2013. {{cite journal}}: Недійсний |displayauthors=6 (довідка) [Архівовано 2013-04-15 у Archive.is]

archivesofpathology.org

Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (November 2005). Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability. Archives of Pathology & Laboratory Medicine. 129 (11): 1390—7. doi:10.1043/1543-2165(2005)129[1390:POTRBG]2.0.CO;2. PMID 16253017.

bowelcanceruk.org.uk

Bowel Cancer UK: Lynch Syndrome. Процитовано 31 березня 2018.

cdc.gov

CDC: March 22nd is National Lynch Syndrome Awareness Day!. 20 березня 2018. Процитовано 31 березня 2018.

doi.org

Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S (October 2009). Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 302 (16): 1790—5. doi:10.1001/jama.2009.1529. PMC 4091624. PMID 19861671. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Møller P, Seppälä TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, Lindblom A, Macrae F, Blanco I, Sijmons RH, Jeffries J, Vasen HF, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen JT, Jenkins MA, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Valentin MD, Frayling IM, Plazzer JP, Pylvanainen K, Genuardi M, Mecklin JP, Moeslein G, Sampson JR, Capella G (July 2018). path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut. 67 (7): 1306—1316. doi:10.1136/gutjnl-2017-314057. PMC 6031262. PMID 28754778. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Ring KL, Garcia C, Thomas MH, Modesitt SC (November 2017). Current and future role of genetic screening in gynecologic malignancies. American Journal of Obstetrics and Gynecology. 217 (5): 512—521. doi:10.1016/j.ajog.2017.04.011. PMID 28411145.
Oki E, Oda S, Maehara Y, Sugimachi K (March 1999). Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair. Oncogene. 18 (12): 2143—7. doi:10.1038/sj.onc.1202583. PMID 10321739.
Yokoyama, Takanori; Takehara, Kazuhiro; Sugimoto, Nao; Kaneko, Keika; Fujimoto, Etsuko; Okazawa-Sakai, Mika; Okame, Shinichi; Shiroyama, Yuko; Yokoyama, Takashi (December 2018). Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review. BMC Cancer. 18 (1): 576. doi:10.1186/s12885-018-4489-0. ISSN 1471-2407. PMC 5963021. PMID 29783979.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Peltomäki, Päivi (15 березня 2003). Role of DNA mismatch repair defects in the pathogenesis of human cancer. Journal of Clinical Oncology. 21 (6): 1174—1179. doi:10.1200/JCO.2003.04.060. ISSN 0732-183X. PMID 12637487.
Tamura, Kazuo; Kaneda, Motohide; Futagawa, Mashu; Takeshita, Miho; Kim, Sanghyuk; Nakama, Mina; Kawashita, Norihito; Tatsumi-Miyajima, Junko (September 2019). Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome. International Journal of Clinical Oncology. 24 (9): 999—1011. doi:10.1007/s10147-019-01494-y. ISSN 1341-9625. PMID 31273487.
Fishel, R.; Lescoe, M. K.; Rao, M. R.; Copeland, N. G.; Jenkins, N. A.; Garber, J.; Kane, M.; Kolodner, R. (3 грудня 1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75 (5): 1027—1038. doi:10.1016/0092-8674(93)90546-3. ISSN 0092-8674. PMID 8252616.
Yurgelun, Matthew B.; Hampel, Heather (23 травня 2018). Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 38 (38): 101—109. doi:10.1200/EDBK_208341. ISSN 1548-8756. PMID 30231390.
Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (December 1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75 (5): 1027—38. doi:10.1016/0092-8674(93)90546-3. PMID 8252616. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD (March 1994). Mutation of a mutL homolog in hereditary colon cancer. Science. 263 (5153): 1625—9. Bibcode:1994Sci...263.1625P. doi:10.1126/science.8128251. PMID 8128251. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, Igari T, Koike M, Chiba M, Mori T (November 1997). Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nature Genetics. 17 (3): 271—2. doi:10.1038/ng1197-271. PMID 9354786. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM (September 1994). Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 371 (6492): 75—80. Bibcode:1994Natur.371...75N. doi:10.1038/371075a0. PMID 8072530. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Lu SL, Kawabata M, Imamura T, Akiyama Y, Nomizu T, Miyazono K, Yuasa Y (May 1998). HNPCC associated with germline mutation in the TGF-beta type II receptor gene. Nature Genetics. 19 (1): 17—8. doi:10.1038/ng0598-17. PMID 9590282.
Ou J, Rasmussen M, Westers H, Andersen SD, Jager PO, Kooi KA, Niessen RC, Eggen BJ, Nielsen FC, Kleibeuker JH, Sijmons RH, Rasmussen LJ, Hofstra RM (April 2009). Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome (PDF). Genes, Chromosomes & Cancer. 48 (4): 340—50. doi:10.1002/gcc.20644. PMID 19156873. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Ramsoekh D, Wagner A, van Leerdam ME, Dinjens WN, Steyerberg EW, Halley DJ, Kuipers EJ, Dooijes D (November 2008). A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting. Gut. 57 (11): 1539—44. doi:10.1136/gut.2008.156695. PMID 18625694. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Suchy J, Lubinski J (June 2008). MSH6 syndrome. Hereditary Cancer in Clinical Practice. 6 (2): 103—4. doi:10.1186/1897-4287-6-2-103. PMC 2735474. PMID 19804606.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Goldberg Y, Porat RM, Kedar I, Shochat C, Galinsky D, Hamburger T, Hubert A, Strul H, Kariiv R, Ben-Avi L, Savion M, Pikarsky E, Abeliovich D, Bercovich D, Lerer I, Peretz T (June 2010). An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC. Familial Cancer. 9 (2): 141—50. doi:10.1007/s10689-009-9298-9. PMID 19851887. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Giardiello, Francis M.; Allen, John I.; Axilbund, Jennifer E.; Boland, C. Richard; Burke, Carol A.; Burt, Randall W.; Church, James M.; Dominitz, Jason A.; Johnson, David A. (August 2014). Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 147 (2): 502—526. doi:10.1053/j.gastro.2014.04.001. PMID 25043945.
Snowsill, Tristan; Huxley, Nicola; Hoyle, Martin; Jones-Hughes, Tracey; Coelho, Helen; Cooper, Chris; Frayling, Ian; Hyde, Chris (September 2014). A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome. Health Technology Assessment. 18 (58): 1—406. doi:10.3310/hta18580. ISSN 1366-5278. PMC 4781313. PMID 25244061.
Snowsill, Tristan; Coelho, Helen; Huxley, Nicola; Jones-Hughes, Tracey; Briscoe, Simon; Frayling, Ian M.; Hyde, Chris (September 2017). Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Health Technology Assessment (Winchester, England). 21 (51): 1—238. doi:10.3310/hta21510. ISSN 2046-4924. PMC 5611555. PMID 28895526.
Evrard, Camille; Tachon, Gaëlle; Randrian, Violaine; Karayan-Tapon, Lucie; Tougeron, David (15 жовтня 2019). Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer. Cancers. 11 (10): 1567. doi:10.3390/cancers11101567. ISSN 2072-6694. PMC 6826728. PMID 31618962.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Burn J, Bishop DT, Mecklin JP, Macrae F, Möslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans DG, Lubinski J, Morrison PJ, Ho JW, Vasen HF, Side L, Thomas HJ, Scott RJ, Dunlop M, Barker G, Elliott F, Jass JR, Fodde R, Lynch HT, Mathers JC (December 2008). Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. The New England Journal of Medicine. 359 (24): 2567—78. doi:10.1056/NEJMoa0801297. PMID 19073976. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Vasen HF, Watson P, Mecklin JP, Lynch HT (June 1999). New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 116 (6): 1453—6. doi:10.1016/S0016-5085(99)70510-X. PMID 10348829.
Vindigni, Stephen M.; Kaz, Andrew M. (2016). Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities. Digestive Diseases and Sciences. 61 (4): 969—976. doi:10.1007/s10620-015-3964-6. ISSN 0163-2116. PMID 26602911.
Bui, Quan M.; Lin, David; Ho, Wendy (February 2017). Approach to Lynch Syndrome for the Gastroenterologist. Digestive Diseases and Sciences. 62 (2): 299—304. doi:10.1007/s10620-016-4346-4. ISSN 0163-2116. PMID 27990589.
Boland CR, Koi M, Chang DK, Carethers JM (2007). The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Familial Cancer. 7 (1): 41—52. doi:10.1007/s10689-007-9145-9. PMC 2847875. PMID 17636426.
Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA (June 2015). PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. The New England Journal of Medicine. 372 (26): 2509—20. doi:10.1056/NEJMoa1500596. PMC 4481136. PMID 26028255. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (February 1966). Hereditary factors in cancer. Study of two large midwestern kindreds. Archives of Internal Medicine. 117 (2): 206—12. doi:10.1001/archinte.117.2.206. PMID 5901552.
Bellizzi AM, Frankel WL (November 2009). Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Advances in Anatomic Pathology. 16 (6): 405—17. doi:10.1097/PAP.0b013e3181bb6bdc. PMID 19851131.
Lindor NM (October 2009). Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome. Surgical Oncology Clinics of North America. 18 (4): 637—45. doi:10.1016/j.soc.2009.07.003. PMC 3454516. PMID 19793571.
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D (April 2005). Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 293 (16): 1979—85. doi:10.1001/jama.293.16.1979. PMC 2933042. PMID 15855431. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, du Sart D, Tucker K, Kirk J (January 2001). Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. American Journal of Human Genetics. 68 (1): 118—127. doi:10.1086/316942. PMC 1234904. PMID 11112663. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (November 2005). Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability. Archives of Pathology & Laboratory Medicine. 129 (11): 1390—7. doi:10.1043/1543-2165(2005)129[1390:POTRBG]2.0.CO;2. PMID 16253017.
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (February 2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute. 96 (4): 261—8. doi:10.1093/jnci/djh034. PMC 2933058. PMID 14970275. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, Cranston T, Izatt L, Sasieni P, Hodgson SV, Thomas HJ, Tomlinson IP (December 2004). Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. Journal of Clinical Oncology. 22 (24): 4934—43. doi:10.1200/JCO.2004.11.084. PMID 15611508. Архів оригіналу за 15 квітня 2013. {{cite journal}}: Недійсний |displayauthors=6 (довідка) [Архівовано 2013-04-15 у Archive.is]

dynamed.com

Lynch Syndrome. DynaMed. 22 лютого 2019. Процитовано 18 листопада 2019.

elsevierhealth.com

journals.elsevierhealth.com

Lindor NM (October 2009). Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome. Surgical Oncology Clinics of North America. 18 (4): 637—45. doi:10.1016/j.soc.2009.07.003. PMC 3454516. PMID 19793571.

genetics.edu.au

Архівована копія. Архів оригіналу за 28 лютого 2019. Процитовано 11 серпня 2020.{{cite web}}: Обслуговування CS1: Сторінки з текстом «archived copy» як значення параметру title (посилання) [Архівовано 2019-02-28 у Wayback Machine.]

harvard.edu

ui.adsabs.harvard.edu

Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD (March 1994). Mutation of a mutL homolog in hereditary colon cancer. Science. 263 (5153): 1625—9. Bibcode:1994Sci...263.1625P. doi:10.1126/science.8128251. PMID 8128251. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM (September 1994). Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 371 (6492): 75—80. Bibcode:1994Natur.371...75N. doi:10.1038/371075a0. PMID 8072530. {{cite journal}}: Недійсний |displayauthors=6 (довідка)

jco.org

Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, Cranston T, Izatt L, Sasieni P, Hodgson SV, Thomas HJ, Tomlinson IP (December 2004). Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. Journal of Clinical Oncology. 22 (24): 4934—43. doi:10.1200/JCO.2004.11.084. PMID 15611508. Архів оригіналу за 15 квітня 2013. {{cite journal}}: Недійсний |displayauthors=6 (довідка) [Архівовано 2013-04-15 у Archive.is]

lynch-syndrome-uk.org

Lynch Syndrome UK. Процитовано 31 березня 2018.

medscape.com

emedicine.medscape.com

Hereditary Colorectal Cancer > Background. From Medscape. By Juan Carlos Munoz and Louis R Lambiase. Updated: Oct 31, 2011

medscape.com

Aspirin Confers Long-Term Protective Effect in Lynch Syndrome Patients. Процитовано 7 листопада 2009.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S (October 2009). Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 302 (16): 1790—5. doi:10.1001/jama.2009.1529. PMC 4091624. PMID 19861671. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Møller P, Seppälä TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, Lindblom A, Macrae F, Blanco I, Sijmons RH, Jeffries J, Vasen HF, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen JT, Jenkins MA, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Valentin MD, Frayling IM, Plazzer JP, Pylvanainen K, Genuardi M, Mecklin JP, Moeslein G, Sampson JR, Capella G (July 2018). path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut. 67 (7): 1306—1316. doi:10.1136/gutjnl-2017-314057. PMC 6031262. PMID 28754778. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Ring KL, Garcia C, Thomas MH, Modesitt SC (November 2017). Current and future role of genetic screening in gynecologic malignancies. American Journal of Obstetrics and Gynecology. 217 (5): 512—521. doi:10.1016/j.ajog.2017.04.011. PMID 28411145.
Oki E, Oda S, Maehara Y, Sugimachi K (March 1999). Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair. Oncogene. 18 (12): 2143—7. doi:10.1038/sj.onc.1202583. PMID 10321739.
Yokoyama, Takanori; Takehara, Kazuhiro; Sugimoto, Nao; Kaneko, Keika; Fujimoto, Etsuko; Okazawa-Sakai, Mika; Okame, Shinichi; Shiroyama, Yuko; Yokoyama, Takashi (December 2018). Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review. BMC Cancer. 18 (1): 576. doi:10.1186/s12885-018-4489-0. ISSN 1471-2407. PMC 5963021. PMID 29783979.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Peltomäki, Päivi (15 березня 2003). Role of DNA mismatch repair defects in the pathogenesis of human cancer. Journal of Clinical Oncology. 21 (6): 1174—1179. doi:10.1200/JCO.2003.04.060. ISSN 0732-183X. PMID 12637487.
Tamura, Kazuo; Kaneda, Motohide; Futagawa, Mashu; Takeshita, Miho; Kim, Sanghyuk; Nakama, Mina; Kawashita, Norihito; Tatsumi-Miyajima, Junko (September 2019). Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome. International Journal of Clinical Oncology. 24 (9): 999—1011. doi:10.1007/s10147-019-01494-y. ISSN 1341-9625. PMID 31273487.
Fishel, R.; Lescoe, M. K.; Rao, M. R.; Copeland, N. G.; Jenkins, N. A.; Garber, J.; Kane, M.; Kolodner, R. (3 грудня 1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75 (5): 1027—1038. doi:10.1016/0092-8674(93)90546-3. ISSN 0092-8674. PMID 8252616.
Yurgelun, Matthew B.; Hampel, Heather (23 травня 2018). Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 38 (38): 101—109. doi:10.1200/EDBK_208341. ISSN 1548-8756. PMID 30231390.
Le, Stephanie; Ansari, Umer; Mumtaz, Aisha; Malik, Kunal; Patel, Parth; Doyle, Amanda; Khachemoune, Amor (15 листопада 2017). Lynch Syndrome and Muir-Torre Syndrome: An update and review on the genetics, epidemiology, and management of two related disorders. Dermatology Online Journal. 23 (11). ISSN 1087-2108. PMID 29447627.
Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (December 1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75 (5): 1027—38. doi:10.1016/0092-8674(93)90546-3. PMID 8252616. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD (March 1994). Mutation of a mutL homolog in hereditary colon cancer. Science. 263 (5153): 1625—9. Bibcode:1994Sci...263.1625P. doi:10.1126/science.8128251. PMID 8128251. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, Igari T, Koike M, Chiba M, Mori T (November 1997). Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nature Genetics. 17 (3): 271—2. doi:10.1038/ng1197-271. PMID 9354786. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM (September 1994). Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 371 (6492): 75—80. Bibcode:1994Natur.371...75N. doi:10.1038/371075a0. PMID 8072530. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Lu SL, Kawabata M, Imamura T, Akiyama Y, Nomizu T, Miyazono K, Yuasa Y (May 1998). HNPCC associated with germline mutation in the TGF-beta type II receptor gene. Nature Genetics. 19 (1): 17—8. doi:10.1038/ng0598-17. PMID 9590282.
Ou J, Rasmussen M, Westers H, Andersen SD, Jager PO, Kooi KA, Niessen RC, Eggen BJ, Nielsen FC, Kleibeuker JH, Sijmons RH, Rasmussen LJ, Hofstra RM (April 2009). Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome (PDF). Genes, Chromosomes & Cancer. 48 (4): 340—50. doi:10.1002/gcc.20644. PMID 19156873. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Ramsoekh D, Wagner A, van Leerdam ME, Dinjens WN, Steyerberg EW, Halley DJ, Kuipers EJ, Dooijes D (November 2008). A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting. Gut. 57 (11): 1539—44. doi:10.1136/gut.2008.156695. PMID 18625694. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Suchy J, Lubinski J (June 2008). MSH6 syndrome. Hereditary Cancer in Clinical Practice. 6 (2): 103—4. doi:10.1186/1897-4287-6-2-103. PMC 2735474. PMID 19804606.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Goldberg Y, Porat RM, Kedar I, Shochat C, Galinsky D, Hamburger T, Hubert A, Strul H, Kariiv R, Ben-Avi L, Savion M, Pikarsky E, Abeliovich D, Bercovich D, Lerer I, Peretz T (June 2010). An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC. Familial Cancer. 9 (2): 141—50. doi:10.1007/s10689-009-9298-9. PMID 19851887. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Giardiello, Francis M.; Allen, John I.; Axilbund, Jennifer E.; Boland, C. Richard; Burke, Carol A.; Burt, Randall W.; Church, James M.; Dominitz, Jason A.; Johnson, David A. (August 2014). Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 147 (2): 502—526. doi:10.1053/j.gastro.2014.04.001. PMID 25043945.
Snowsill, Tristan; Huxley, Nicola; Hoyle, Martin; Jones-Hughes, Tracey; Coelho, Helen; Cooper, Chris; Frayling, Ian; Hyde, Chris (September 2014). A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome. Health Technology Assessment. 18 (58): 1—406. doi:10.3310/hta18580. ISSN 1366-5278. PMC 4781313. PMID 25244061.
Snowsill, Tristan; Coelho, Helen; Huxley, Nicola; Jones-Hughes, Tracey; Briscoe, Simon; Frayling, Ian M.; Hyde, Chris (September 2017). Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Health Technology Assessment (Winchester, England). 21 (51): 1—238. doi:10.3310/hta21510. ISSN 2046-4924. PMC 5611555. PMID 28895526.
Evrard, Camille; Tachon, Gaëlle; Randrian, Violaine; Karayan-Tapon, Lucie; Tougeron, David (15 жовтня 2019). Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer. Cancers. 11 (10): 1567. doi:10.3390/cancers11101567. ISSN 2072-6694. PMC 6826728. PMID 31618962.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Burn J, Bishop DT, Mecklin JP, Macrae F, Möslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans DG, Lubinski J, Morrison PJ, Ho JW, Vasen HF, Side L, Thomas HJ, Scott RJ, Dunlop M, Barker G, Elliott F, Jass JR, Fodde R, Lynch HT, Mathers JC (December 2008). Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. The New England Journal of Medicine. 359 (24): 2567—78. doi:10.1056/NEJMoa0801297. PMID 19073976. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Vasen HF, Watson P, Mecklin JP, Lynch HT (June 1999). New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 116 (6): 1453—6. doi:10.1016/S0016-5085(99)70510-X. PMID 10348829.
Vindigni, Stephen M.; Kaz, Andrew M. (2016). Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities. Digestive Diseases and Sciences. 61 (4): 969—976. doi:10.1007/s10620-015-3964-6. ISSN 0163-2116. PMID 26602911.
Bui, Quan M.; Lin, David; Ho, Wendy (February 2017). Approach to Lynch Syndrome for the Gastroenterologist. Digestive Diseases and Sciences. 62 (2): 299—304. doi:10.1007/s10620-016-4346-4. ISSN 0163-2116. PMID 27990589.
Boland CR, Koi M, Chang DK, Carethers JM (2007). The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Familial Cancer. 7 (1): 41—52. doi:10.1007/s10689-007-9145-9. PMC 2847875. PMID 17636426.
Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA (June 2015). PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. The New England Journal of Medicine. 372 (26): 2509—20. doi:10.1056/NEJMoa1500596. PMC 4481136. PMID 26028255. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (February 1966). Hereditary factors in cancer. Study of two large midwestern kindreds. Archives of Internal Medicine. 117 (2): 206—12. doi:10.1001/archinte.117.2.206. PMID 5901552.
Bellizzi AM, Frankel WL (November 2009). Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Advances in Anatomic Pathology. 16 (6): 405—17. doi:10.1097/PAP.0b013e3181bb6bdc. PMID 19851131.
Lindor NM (October 2009). Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome. Surgical Oncology Clinics of North America. 18 (4): 637—45. doi:10.1016/j.soc.2009.07.003. PMC 3454516. PMID 19793571.
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D (April 2005). Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 293 (16): 1979—85. doi:10.1001/jama.293.16.1979. PMC 2933042. PMID 15855431. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, du Sart D, Tucker K, Kirk J (January 2001). Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. American Journal of Human Genetics. 68 (1): 118—127. doi:10.1086/316942. PMC 1234904. PMID 11112663. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (November 2005). Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability. Archives of Pathology & Laboratory Medicine. 129 (11): 1390—7. doi:10.1043/1543-2165(2005)129[1390:POTRBG]2.0.CO;2. PMID 16253017.
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (February 2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute. 96 (4): 261—8. doi:10.1093/jnci/djh034. PMC 2933058. PMID 14970275. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, Cranston T, Izatt L, Sasieni P, Hodgson SV, Thomas HJ, Tomlinson IP (December 2004). Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. Journal of Clinical Oncology. 22 (24): 4934—43. doi:10.1200/JCO.2004.11.084. PMID 15611508. Архів оригіналу за 15 квітня 2013. {{cite journal}}: Недійсний |displayauthors=6 (довідка) [Архівовано 2013-04-15 у Archive.is]

ncbi.nlm.nih.gov

Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S (October 2009). Risk of pancreatic cancer in families with Lynch syndrome. JAMA. 302 (16): 1790—5. doi:10.1001/jama.2009.1529. PMC 4091624. PMID 19861671. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Møller P, Seppälä TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, Lindblom A, Macrae F, Blanco I, Sijmons RH, Jeffries J, Vasen HF, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen JT, Jenkins MA, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Valentin MD, Frayling IM, Plazzer JP, Pylvanainen K, Genuardi M, Mecklin JP, Moeslein G, Sampson JR, Capella G (July 2018). path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut. 67 (7): 1306—1316. doi:10.1136/gutjnl-2017-314057. PMC 6031262. PMID 28754778. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Yokoyama, Takanori; Takehara, Kazuhiro; Sugimoto, Nao; Kaneko, Keika; Fujimoto, Etsuko; Okazawa-Sakai, Mika; Okame, Shinichi; Shiroyama, Yuko; Yokoyama, Takashi (December 2018). Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review. BMC Cancer. 18 (1): 576. doi:10.1186/s12885-018-4489-0. ISSN 1471-2407. PMC 5963021. PMID 29783979.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Suchy J, Lubinski J (June 2008). MSH6 syndrome. Hereditary Cancer in Clinical Practice. 6 (2): 103—4. doi:10.1186/1897-4287-6-2-103. PMC 2735474. PMID 19804606.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Snowsill, Tristan; Huxley, Nicola; Hoyle, Martin; Jones-Hughes, Tracey; Coelho, Helen; Cooper, Chris; Frayling, Ian; Hyde, Chris (September 2014). A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome. Health Technology Assessment. 18 (58): 1—406. doi:10.3310/hta18580. ISSN 1366-5278. PMC 4781313. PMID 25244061.
Snowsill, Tristan; Coelho, Helen; Huxley, Nicola; Jones-Hughes, Tracey; Briscoe, Simon; Frayling, Ian M.; Hyde, Chris (September 2017). Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Health Technology Assessment (Winchester, England). 21 (51): 1—238. doi:10.3310/hta21510. ISSN 2046-4924. PMC 5611555. PMID 28895526.
Evrard, Camille; Tachon, Gaëlle; Randrian, Violaine; Karayan-Tapon, Lucie; Tougeron, David (15 жовтня 2019). Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer. Cancers. 11 (10): 1567. doi:10.3390/cancers11101567. ISSN 2072-6694. PMC 6826728. PMID 31618962.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Boland CR, Koi M, Chang DK, Carethers JM (2007). The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Familial Cancer. 7 (1): 41—52. doi:10.1007/s10689-007-9145-9. PMC 2847875. PMID 17636426.
Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA (June 2015). PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. The New England Journal of Medicine. 372 (26): 2509—20. doi:10.1056/NEJMoa1500596. PMC 4481136. PMID 26028255. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Lindor NM (October 2009). Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome. Surgical Oncology Clinics of North America. 18 (4): 637—45. doi:10.1016/j.soc.2009.07.003. PMC 3454516. PMID 19793571.
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D (April 2005). Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 293 (16): 1979—85. doi:10.1001/jama.293.16.1979. PMC 2933042. PMID 15855431. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, du Sart D, Tucker K, Kirk J (January 2001). Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. American Journal of Human Genetics. 68 (1): 118—127. doi:10.1086/316942. PMC 1234904. PMID 11112663. {{cite journal}}: Недійсний |displayauthors=6 (довідка)
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (February 2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute. 96 (4): 261—8. doi:10.1093/jnci/djh034. PMC 2933058. PMID 14970275. {{cite journal}}: Недійсний |displayauthors=6 (довідка)

rarediseases.info.nih.gov

Lynch syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. rarediseases.info.nih.gov. Архів оригіналу за 16 липня 2019. Процитовано 4 жовтня 2019. [Архівовано 2019-07-16 у Wayback Machine.]

ghr.nlm.nih.gov

Lynch Syndrome. Genetics Home Reference.

oxfordjournals.org

jnci.oxfordjournals.org

Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (February 2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute. 96 (4): 261—8. doi:10.1093/jnci/djh034. PMC 2933058. PMID 14970275. {{cite journal}}: Недійсний |displayauthors=6 (довідка)

rug.nl

pure.rug.nl

Ou J, Rasmussen M, Westers H, Andersen SD, Jager PO, Kooi KA, Niessen RC, Eggen BJ, Nielsen FC, Kleibeuker JH, Sijmons RH, Rasmussen LJ, Hofstra RM (April 2009). Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome (PDF). Genes, Chromosomes & Cancer. 48 (4): 340—50. doi:10.1002/gcc.20644. PMID 19156873. {{cite journal}}: Недійсний |displayauthors=6 (довідка)

web.archive.org

Lynch syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. rarediseases.info.nih.gov. Архів оригіналу за 16 липня 2019. Процитовано 4 жовтня 2019. [Архівовано 2019-07-16 у Wayback Machine.]
Архівована копія. Архів оригіналу за 28 лютого 2019. Процитовано 11 серпня 2020.{{cite web}}: Обслуговування CS1: Сторінки з текстом «archived copy» як значення параметру title (посилання) [Архівовано 2019-02-28 у Wayback Machine.]

worldcat.org

search.worldcat.org

Yokoyama, Takanori; Takehara, Kazuhiro; Sugimoto, Nao; Kaneko, Keika; Fujimoto, Etsuko; Okazawa-Sakai, Mika; Okame, Shinichi; Shiroyama, Yuko; Yokoyama, Takashi (December 2018). Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review. BMC Cancer. 18 (1): 576. doi:10.1186/s12885-018-4489-0. ISSN 1471-2407. PMC 5963021. PMID 29783979.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Peltomäki, Päivi (15 березня 2003). Role of DNA mismatch repair defects in the pathogenesis of human cancer. Journal of Clinical Oncology. 21 (6): 1174—1179. doi:10.1200/JCO.2003.04.060. ISSN 0732-183X. PMID 12637487.
Tamura, Kazuo; Kaneda, Motohide; Futagawa, Mashu; Takeshita, Miho; Kim, Sanghyuk; Nakama, Mina; Kawashita, Norihito; Tatsumi-Miyajima, Junko (September 2019). Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome. International Journal of Clinical Oncology. 24 (9): 999—1011. doi:10.1007/s10147-019-01494-y. ISSN 1341-9625. PMID 31273487.
Fishel, R.; Lescoe, M. K.; Rao, M. R.; Copeland, N. G.; Jenkins, N. A.; Garber, J.; Kane, M.; Kolodner, R. (3 грудня 1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75 (5): 1027—1038. doi:10.1016/0092-8674(93)90546-3. ISSN 0092-8674. PMID 8252616.
Yurgelun, Matthew B.; Hampel, Heather (23 травня 2018). Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 38 (38): 101—109. doi:10.1200/EDBK_208341. ISSN 1548-8756. PMID 30231390.
Le, Stephanie; Ansari, Umer; Mumtaz, Aisha; Malik, Kunal; Patel, Parth; Doyle, Amanda; Khachemoune, Amor (15 листопада 2017). Lynch Syndrome and Muir-Torre Syndrome: An update and review on the genetics, epidemiology, and management of two related disorders. Dermatology Online Journal. 23 (11). ISSN 1087-2108. PMID 29447627.
Snowsill, Tristan; Huxley, Nicola; Hoyle, Martin; Jones-Hughes, Tracey; Coelho, Helen; Cooper, Chris; Frayling, Ian; Hyde, Chris (September 2014). A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome. Health Technology Assessment. 18 (58): 1—406. doi:10.3310/hta18580. ISSN 1366-5278. PMC 4781313. PMID 25244061.
Snowsill, Tristan; Coelho, Helen; Huxley, Nicola; Jones-Hughes, Tracey; Briscoe, Simon; Frayling, Ian M.; Hyde, Chris (September 2017). Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation. Health Technology Assessment (Winchester, England). 21 (51): 1—238. doi:10.3310/hta21510. ISSN 2046-4924. PMC 5611555. PMID 28895526.
Evrard, Camille; Tachon, Gaëlle; Randrian, Violaine; Karayan-Tapon, Lucie; Tougeron, David (15 жовтня 2019). Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer. Cancers. 11 (10): 1567. doi:10.3390/cancers11101567. ISSN 2072-6694. PMC 6826728. PMID 31618962.{{cite journal}}: Обслуговування CS1: Сторінки із непозначеним DOI з безкоштовним доступом (посилання)
Vindigni, Stephen M.; Kaz, Andrew M. (2016). Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities. Digestive Diseases and Sciences. 61 (4): 969—976. doi:10.1007/s10620-015-3964-6. ISSN 0163-2116. PMID 26602911.
Bui, Quan M.; Lin, David; Ho, Wendy (February 2017). Approach to Lynch Syndrome for the Gastroenterologist. Digestive Diseases and Sciences. 62 (2): 299—304. doi:10.1007/s10620-016-4346-4. ISSN 0163-2116. PMID 27990589.